Reuters logo
BRIEF-NANOVIRICIDES SAYS HAS SUFFICIENT CASH TO ADVANCE INTO CLINICAL TRIALS
September 29, 2017 / 11:35 AM / 24 days ago

BRIEF-NANOVIRICIDES SAYS HAS SUFFICIENT CASH TO ADVANCE INTO CLINICAL TRIALS

Sept 29 (Reuters) - NanoViricides Inc:

* NANOVIRICIDES HAS FILED ANNUAL REPORT, SAYS COMPANY HAS SUFFICIENT CASH TO ADVANCE INTO CLINICAL TRIALS

* SAYS ‍DOES NOT ANTICIPATE ANY MAJOR CAPITAL COSTS GOING FORWARD IN NEAR FUTURE​

* SAYS ‍BELIEVES THAT CO HAS SUFFICIENT FUNDS IN HAND TO LAST MORE THAN ONE YEAR​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below